MedPath

SINCALIDE FOR INJECTION

SINCALIDE FOR INJECTION

Approved
DIN Number

02494361

Drug Class

Human

Market Date

Aug 3, 2023

Company
HC

avir pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494361
AIG Number0113162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V04CC03 SINCALIDE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification36:34.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SINCALIDEActive
Strength: 5 MCG / VIAL
Monograph: SINCALIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.